These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10858591)

  • 1. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?
    Praticò D; Trojanowski JQ
    Neurobiol Aging; 2000; 21(3):441-5; discussion 451-3. PubMed ID: 10858591
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
    Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, type 2 diabetes, and AD: cerebrovascular disease or neurodegeneration?
    Luchsinger JA
    Neurology; 2010 Aug; 75(9):758-9. PubMed ID: 20739648
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.
    Hüll M; Fiebich BL; Lieb K; Strauss S; Berger SS; Volk B; Bauer J
    Neurobiol Aging; 1996; 17(5):795-800. PubMed ID: 8892354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
    Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
    Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease: an inflammatory disease?
    Fassbender K; Masters C; Beyreuther K
    Neurobiol Aging; 2000; 21(3):433-6; discussion 451-3. PubMed ID: 10858589
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid immunization in Alzheimer's disease: do we promote amyloid scavenging at the cost of inflammatory degeneration?
    Pasinetti GM; Ho L; Pompl P
    Neurobiol Aging; 2002; 23(5):665-6. PubMed ID: 12392767
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.
    Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S
    Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the development of therapeutics for Alzheimer's disease.
    Davies P
    Neurobiol Aging; 1994; 15 Suppl 2():S53-4. PubMed ID: 7700461
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular aspects of neurodegeneration in Alzheimer's disease.
    Russo C; Venezia V; Salis S; Dolcini V; Schettini G
    Funct Neurol; 2002; 17(2):65-70. PubMed ID: 12224792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA
    Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
    Brenner SR
    Neurology; 2005 Jun; 64(11):1991; author reply 1991. PubMed ID: 15955973
    [No Abstract]   [Full Text] [Related]  

  • 15. Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?
    de la Torre JC
    Ann Neurol; 2005 Jun; 57(6):783-4. PubMed ID: 15929049
    [No Abstract]   [Full Text] [Related]  

  • 16. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
    FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brain's microenvironment, early functional loss, and the conversion to Alzheimer's disease.
    Cotman CW; Anderson AJ
    Ann N Y Acad Sci; 2000; 924():112-6. PubMed ID: 11193787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.
    Kostrzewa RM; Segura-Aguilar J
    Neurotox Res; 2003; 5(6):375-83. PubMed ID: 14715440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's disease.
    Nixon RA
    Neurobiol Aging; 1994; 15 Suppl 2():S61-5. PubMed ID: 7700464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.